tm
Seeing Is Believing
tm
Seeing Is Believing
Verve Therapeutics's activity chart (see below) currently has 49 price targets and 40 ratings on display.
Analysts average stock forecasts to be materialized ratio is 5.21% with an average time for these price targets to be met of 0.63 days.
Most recent stock forecast was given by from OPPENHEIMER on 27-Jun-2025. First documented stock forecast 12-Jul-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Jun-2022
$13.5
1 years 2 months 19 days ago
(27-Jun-2025)
0/6 (0%)
$2.24 (19.89%)
Buy Since 09-May-2024
$13.5
$2.37 (21.29%)
$15
1 years 2 months 28 days ago
(18-Jun-2025)
0/7 (0%)
$2.38 (21.40%)
Buy Since 13-Apr-2023
$13
$1.87 (16.80%)
$39
1 years 2 months 29 days ago
(17-Jun-2025)
0/9 (0%)
$1.62 (14.24%)
Hold Since 12-Jul-2021
$16
$4.87 (43.76%)
$19
1 years 5 months ago
(15-Apr-2025)
1/4 (25%)
$11.03 (221.93%)
1
Buy Since 12-Jul-2021
$24
$12.87 (115.63%)
1 years 5 months ago
(15-Apr-2025)
0/2 (0%)
$19.03 (382.90%)
What is VERV (Verve Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on VERV (Verve Therapeutics)?
Which analyst has the most public recommendations on VERV (Verve Therapeutics)?
Which analyst is the currently most bullish on VERV (Verve Therapeutics)?
Which analyst is the currently most reserved on VERV (Verve Therapeutics)?
